This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. NVIDIA (NASDAQ: NVDA ) shares were up 5.7% ...

SALT LAKE CITY, UT, April 22, 2020 -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on.

SINTX Technologies, Inc. (SINT) (the “Company”), an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today announced that it has retained Ascendiant Capital Markets, LLC of Irvine, California, Member FINRA & SIPC (“Ascendiant Capital”), as investment bank and advisor, to identify strategic opportunities in the dental space. “While we have been working closely with dental implant companies in specific development projects, Ascendiant Capital will play a critical role in disseminating our R&D advancements to a wider audience of partners, and helping commercialize the technology,” stated Dr. Sonny Bal, President and CEO of SINTX. “We are excited to represent SINTX Technologies, having deep experience and knowledge of dental companies worldwide,” said Dr. Christopher Gayde, a former practicing dentist and Managing Director of Ascendiant Capital’s Dental Investment Banking Group.

Basic science and clinical data have repeatedly shown the efficacy and safety of silicon nitride as a spinal implant material. Of interest is a particularly unique property of silicon nitride, i.e., its ability as a biomaterial to resist bacterial adhesion, a precursor to implant-related infections.

SALT LAKE CITY, March 25, 2020 -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on.

The FDA-registered silicon nitride medical device manufacturing facility company SINTX Technologies Inc (NASDAQ: SINT ) boasts five near-term catalysts that should help the stock double in value, according ...

If you're interested in Sintx Technologies, Inc. (NASDAQ:SINT), then you might want to consider its beta (a measure of...

The companies have agreed to terms whereby Nissin and SINTX will fund research and product development activities collaboratively at a newly developed joint research center, located in Kyoto, Japan. The purpose of this collaboration is to develop new products for worldwide markets, using SINTX’s unique technology and knowledge in silicon nitride ceramics, and Nissin’s superior manufacturing technology platforms and retail channels.

SINTX Technologies, Inc. (SINT) (the “Company”), an original equipment manufacturer (OEM) ceramics company that develops and commercializes silicon nitride, today announced preliminary financial results for the year ended December 31, 2019 and provided a business update. SINTX reported revenue of $0.7 million for the year ended December 31, 2019 as compared to $0.1 million for the year ended December 31, 2018. Further, the Company reported generally accepted accounting principles (GAAP) basic net loss from continuing operations for the year ended December 31, 2019 of $3.08 per share, compared to a basic net loss from continuing operations of $26.57 per share for the year ended December 31, 2018.

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Sintx Technologies (NASDAQ: SINT ) shares ...

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. ACADIA Pharmaceuticals (NASDAQ: ACAD ) shares ...

Warrior Trading is a content partner of Benzinga. This post did not go through the Benzinga Newsdesk. Well, it took a half a month of struggles, but this Thursday marks the first time in August that I’ve ...

SINTX Technologies, Inc. (SINT) (the “Company”), an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today announced financial results for the three and six months ended June 30, 2019 and that it received notice from Nasdaq Regulation that it is now compliant with the minimum bid price requirement for continued listing on the Nasdaq Stock Market. For the six months ended June 30, 2019, the Company reported GAAP basic net loss from continuing operations of $2.84 per share, compared to a basic net loss from continuing operations of $36.66 per share for the six months ended June 30, 2018. The Company's cash and cash equivalents were $3.2 million as of June 30, 2019, a decrease of $2.2 million from December 31, 2018.

SALT LAKE CITY, UT, Nov. 18, 2019 -- SINTX Technologies, Inc. (NASDAQ: SINT) (the “Company”), an original equipment manufacturer (OEM) ceramics company that develops and.

Security holders are advised that open market purchases of SINTX's common stock be completed by Wednesday, January 15, 2020 to be considered a stockholder of record on Friday, January 17, 2020. Holders of the Company's Series B Preferred Shares and warrants issued September 11, 2015, April 4, 2016, April 28, 2016, July 8, 2016, January 20, 2017, and May 14, 2018 are also entitled to participate in the rights offering on the same terms as the common stockholders (collectively, the “Security Holders”).

The subscription period for its previously announced rights offering of units at a subscription price of $1,000 per unit, consisting of one share of Series C Convertible Preferred Stock with a face value of $1,000 (and immediately convertible into shares of SINTX's common stock at a conversion price of $1.4814 per share) and 675 warrants to purchase SINTX's common stock with an exercise price of $1.50 per share, expired on February 3, 2020, and these rights are no longer exercisable (the “Offering”). The subscriptions totaled approximately 14,410 units (approximately 53% oversubscribed).

Dr. Froimson is currently a Principal at Riverside Health Advisors, a consulting company that provides strategic advice and services to health care executive leaders. Dr. Froimson served as past President of the American Association of Hip and Knee Surgeons, and as the Executive Vice President and Chief Clinical Officer of Trinity Health, a national non-profit Catholic healthcare system comprising 93 hospitals in 22 states.

SINTX Technologies, Inc. (SINT) (the “Company”), an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today provided an update on its patent portfolio. The Company announced the provisional filing of a new patent titled “Methods of Surface Functionalization of Zirconia-Toughened Alumina with Silicon Nitride.” “This innovation expands the scope of our technology yet further, by enabling the surface transformation of zirconia-toughened alumina (ZTA), a material widely used in hip replacements worldwide,” said Dr. Sonny Bal, Chairman of SINTX Technologies. “ZTA has proven durability as a weight-bearing implant for decades, but its surface chemistry precludes bone healing.

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

If exercising subscription rights through a broker, dealer, bank or other nominee, rights holders should promptly contact their nominee and submit subscription documents and payment for the units subscribed for in accordance with the instructions and within the time period provided by such nominee. The broker, dealer, bank or other nominee may establish a deadline before February 3, 2020, by which instructions to exercise subscription rights, along with the required subscription payment, must be received.